Letters to the Editor: Long-term Treatment with Tofacitinib in Severe Alopecia Areata: An Update
Dear Editor: Tofacitinib is a Janus kinase (JAK) 1/3 inhibitor that has been approved by the United States Food and Drug Administration for the treatment of rheumatoid arthritis, psoriatic arthritis,